Sandbox JA: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) |
||
| Line 5: | Line 5: | ||
* Frequent occurrence of [[meningitis]] | * Frequent occurrence of [[meningitis]] | ||
* Presence of latent [[spores]] must be taken into account when selecting postexposure [[prophylaxis]] or a combination of [[antibiotics]] for treatment of [[anthrax]]. | * Presence of latent [[spores]] must be taken into account when selecting postexposure [[prophylaxis]] or a combination of [[antibiotics]] for treatment of [[anthrax]]. | ||
Hospitalized patients for systemic [[anthrax]] should be immediately treated with a combination of [[broad-spectrum]] [[intravenous]] [[antimicrobial drug]] treatment pending confirmatory test results because any delay may prove fatal. | |||
==Antimicrobial Treatment== | ==Antimicrobial Treatment== | ||
Revision as of 14:29, 17 July 2014
Medical Therapy
The treatment of anthrax infection includes antimicrobial and antitoxin agents. This treatment and postexposure prophylaxis differs from other bacterial infections because:
- Production of toxin
- Potential antibiotic resistance
- Frequent occurrence of meningitis
- Presence of latent spores must be taken into account when selecting postexposure prophylaxis or a combination of antibiotics for treatment of anthrax.
Hospitalized patients for systemic anthrax should be immediately treated with a combination of broad-spectrum intravenous antimicrobial drug treatment pending confirmatory test results because any delay may prove fatal.